JOSEPH BATA: Open Payments
NPI 1750972113 · ROCHESTER HILLS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,184 in 59 payments from 28 companies in 2025. Trend: 2023 $1,276 · 2024 $1,369 · 2025 $1,184
Food & beverage: $1,184
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $161 |
| Amgen Inc. | 6 | $112 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $83 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $67 |
| Ascendis Pharma Endocrinology Inc | 3 | $62 |
| Corcept Therapeutics | 3 | $60 |
| ABBVIE INC. | 3 | $54 |
| Verity Pharmaceuticals Inc. | 2 | $48 |
| Dexcom, Inc. | 2 | $47 |
| Amneal Pharmaceuticals LLC | 2 | $43 |
Products named: Ozempic, JARDIANCE, Kerendia, Yorvipath, EVENITY, Korlym, Wegovy, UBRELVY.
Industry payments across MI — which companies pay providers there.
